Mahoney David L
MAHONEY DAVID L, DIR, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 4984.000000 shares for an estimated $585478.45. Reported holdings after the transaction were 1232161.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,237,145 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CORT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-359255 Common Stock
- Transaction date
- Aug 18, 2026 Filed Aug 20, 2026, 08:30 PM · 2d delay
- Shares
- 4,984 sh $117.47 per share
- Estimated value
- -$585k Computed from shares × price
- Holdings after
- 1,232,161 sh Indirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale pric…
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale pric…
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale pric…
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale pr…
0 other transactions
0 recent txs